Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Net Income: 2018-2024

Historic Net Income for Silence Therapeutics (SLN) over the last 7 years, with Dec 2024 value amounting to -$45.3 million.

  • Silence Therapeutics' Net Income rose 41.04% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.5 million, marking a year-over-year increase of 15.29%. This contributed to the annual value of -$45.3 million for FY2024, which is 16.45% up from last year.
  • As of FY2024, Silence Therapeutics' Net Income stood at -$45.3 million, which was up 16.45% from -$54.2 million recorded in FY2023.
  • Over the past 5 years, Silence Therapeutics' Net Income peaked at -$41.8 million during FY2020, and registered a low of -$59.3 million during FY2022.
  • Its 3-year average for Net Income is -$52.9 million, with a median of -$54.2 million in 2023.
  • Its Net Income has fluctuated over the past 5 years, first plummeted by 67.16% in 2020, then grew by 16.45% in 2024.
  • Over the past 5 years, Silence Therapeutics' Net Income (Yearly) stood at -$41.8 million in 2020, then fell by 29.74% to -$54.2 million in 2021, then fell by 9.38% to -$59.3 million in 2022, then rose by 8.57% to -$54.2 million in 2023, then climbed by 16.45% to -$45.3 million in 2024.